Primary pulmonary hypertension.
暂无分享,去创建一个
L. Rubin | S. Gaine | S P Gaine | L J Rubin | L. J. Rubin
[1] R. Bolman,et al. Primary pulmonary hypertension as a risk factor for the development of obliterative bronchiolitis in lung allograft recipients. , 1996, Chest.
[2] J Benichou,et al. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group. , 1996, The New England journal of medicine.
[3] T. Saji,et al. Short-term hemodynamic effect of a new oral PGI2 analogue, beraprost, in primary and secondary pulmonary hypertension. , 1996, The American journal of cardiology.
[4] R. Novick,et al. The Registry of the International Society for Heart and Lung Transplantation: thirteenth official report--1996. , 1996, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[5] W. Seeger,et al. Aerosolized Prostacyclin and Iloprost in Severe Pulmonary Hypertension , 1996, Annals of Internal Medicine.
[6] B. Groves,et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. , 1996, The New England journal of medicine.
[7] I. Friehs,et al. Inhaled Nitric Oxide versus Inhaled Prostacyclin and Intravenous versus Inhaled Prostacyclin in Acute Respiratory Failure with Pulmonary Hypertension in Piglets , 1995, Pediatric Research.
[8] A Giaid,et al. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. , 1995, The New England journal of medicine.
[9] T. Foroud,et al. Genetic anticipation and abnormal gender ratio at birth in familial primary pulmonary hypertension. , 1995, American journal of respiratory and critical care medicine.
[10] G. Snell,et al. Inhaled nitric oxide used as a bridge to heart-lung transplantation in a patient with end-stage pulmonary hypertension. , 1995, American journal of respiratory and critical care medicine.
[11] W. Gersony,et al. Blade balloon atrial septostomy in patients with severe primary pulmonary hypertension. , 1995, Circulation.
[12] A. Denjean,et al. Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin. , 1995, American journal of respiratory and critical care medicine.
[13] R. Barst,et al. Survival in Primary Pulmonary Hypertension with Long-Term Continuous Intravenous Prostacyclin , 1994, Annals of Internal Medicine.
[14] G. Simonneau,et al. Pulmonary hypertension in patients with human immunodeficiency virus infection. Comparison with primary pulmonary hypertension. , 1994, Circulation.
[15] J. E. Hansen,et al. Principles of Exercise Testing and Interpretation , 1994 .
[16] G. Simonneau,et al. Primary pulmonary hypertension and fenfluramine use. , 1993, British heart journal.
[17] V. Fuster,et al. Prostacyclin (epoprostenol) and heart-lung transplantation as treatments for severe pulmonary hypertension. , 1993, British heart journal.
[18] T. Petty,et al. Pulmonary hypertension associated with long-term inhalation of "crank" methamphetamine. , 1993, Chest.
[19] D. Stewart,et al. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. , 1993, The New England journal of medicine.
[20] B. Groves,et al. CORRELATION OF ACUTE PROSTACYCLIN RESPONSE IN PRIMARY (UNEXPLAINED) PULMONARY HYPERTENSION WITH EFFICACY OF TREATMENT WITH CALCIUM CHANNEL BLOCKERS AND SURVIVAL , 1993 .
[21] B. Groves,et al. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. , 1992, The New England journal of medicine.
[22] S. Rich,et al. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. , 1992, The New England journal of medicine.
[23] M. Pasque,et al. Single‐Lung Transplantation for Pulmonary Hypertension: Three‐Month Hemodynamic Follow‐up , 1991, Circulation.
[24] T. Higenbottam,et al. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension , 1991, The Lancet.
[25] R. Speich,et al. Primary pulmonary hypertension in HIV infection. , 1991, Chest.
[26] E H Bergofsky,et al. Survival in Patients with Primary Pulmonary Hypertension: Results from a National Prospective Registry , 1991 .
[27] T. Evans,et al. Adenosine as a Vasodilator in Primary Pulmonary Hypertension , 1991, Circulation.
[28] L. Rubin,et al. Reversible pulmonary hypertension associated with anorexigen use. , 1991, The American journal of medicine.
[29] J. H. Diehl,et al. Treatment of Primary Pulmonary Hypertension with Continuous Intravenous Prostacyclin (Epoprostenol): Results of a Randomized Trial , 1990 .
[30] B. Groves,et al. Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry. , 1989, Circulation.
[31] H. Palevsky,et al. Classification of Histologic Lesions in Primary Pulmonary Hypertension Group Medial lesions Intimal lesions Medial hypertrophy Increased smooth muscle , 2005 .
[32] R. Herfkens,et al. Cine-gradient-refocused MR imaging of central pulmonary emboli. , 1989, AJR. American journal of roentgenology.
[33] P. Davies. How Do Vascular Endothelial Cells Respond to Flow , 1989 .
[34] M. Gómez-Sánchez,et al. Pulmonary hypertension due to toxic oil syndrome. A clinicopathologic study. , 1989, Chest.
[35] B. Groves,et al. The acute administration of vasodilators in primary pulmonary hypertension. Experience from the National Institutes of Health Registry on Primary Pulmonary Hypertension. , 1989, The American review of respiratory disease.
[36] M. Rabinovitch,et al. Endothelial injury and vascular reactivity in monocrotaline pulmonary hypertension. , 1988, The American journal of physiology.
[37] R. Virmani,et al. Heterogeneity of pathologic lesions in familial primary pulmonary hypertension. , 1988, The American review of respiratory disease.
[38] J. Rouleau,et al. Familial pulmonary capillary hemangiomatosis resulting in primary pulmonary hypertension. , 1988, Annals of internal medicine.
[39] T. Driscol,et al. Primary pulmonary hypertension in patients with classic hemophilia. , 1988, Annals of internal medicine.
[40] W. Ashburn,et al. Perfusion lung scans provide a guide to which patients with apparent primary pulmonary hypertension merit angiography. , 1988, The Western journal of medicine.
[41] F. Keeley,et al. Altered elastin and collagen synthesis associated with progressive pulmonary hypertension induced by monocrotaline. A biochemical and ultrastructural study. , 1988, Laboratory investigation; a journal of technical methods and pathology.
[42] S. Hunt,et al. Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease. , 1982, The New England journal of medicine.
[43] W. Edwards,et al. Coexistent pulmonary and portal hypertension: morphologic and clinical features. , 1987, Journal of the American College of Cardiology.
[44] D. Buff. Primary pulmonary hypertension. , 1987, Annals of internal medicine.
[45] C. Lombard,et al. Pulmonary veno-occlusive disease following therapy for malignant neoplasms. , 1987, Chest.
[46] W. Williams,et al. Abnormal endothelial factor VIII associated with pulmonary hypertension and congenital heart defects. , 1987, Circulation.
[47] K. Peterson,et al. Pulmonary angiography in severe chronic pulmonary hypertension. , 1987, Annals of internal medicine.
[48] E H Bergofsky,et al. Primary pulmonary hypertension. A national prospective study. , 1987, Annals of internal medicine.
[49] A. Zinsmeister,et al. Anatomic and functional significance of a hypotensive response during supine exercise radionuclide ventriculography. , 1987, The American journal of cardiology.
[50] B. Brundage,et al. High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy. , 1987, Circulation.
[51] E. Robin,et al. PRIMARY PULMONARY HYPERTENSION , 2022 .
[52] T. Higenbottam,et al. Treatment of primary pulmonary hypertension intravenous epoprostenol (prostacyclin). , 1987, British heart journal.
[53] L. Hoyer,et al. von Willebrand factor abnormalities in primary pulmonary hypertension. , 1987, The American review of respiratory disease.
[54] B. Brundage,et al. Doppler echocardiography assessment of impaired left ventricular filling in patients with right ventricular pressure overload due to primary pulmonary hypertension , 1986 .
[55] B. Brundage,et al. Antinuclear antibodies in primary pulmonary hypertension. , 1986, Journal of the American College of Cardiology.
[56] Wiedemann Hp. Wedge pressure in pulmonary veno-occlusive disease. , 1986 .
[57] B. Brundage,et al. Primary pulmonary hypertension: radiographic and scintigraphic patterns of histologic subtypes. , 1986, Annals of internal medicine.
[58] A. Kitabatake,et al. Continuous-wave Doppler echocardiographic detection of pulmonary regurgitation and its application to noninvasive estimation of pulmonary artery pressure. , 1986, Circulation.
[59] M. Pepi,et al. Hypersensitivity of lung vessels to catecholamines in systemic hypertension. , 1986, British medical journal.
[60] B. Groves,et al. The case for treatment of selected patients with primary pulmonary hypertension. , 1986, The American review of respiratory disease.
[61] P. Bloomfield,et al. Irreversible pulmonary hypertension after treatment with fenfluramine. , 1986, British medical journal.
[62] S. Capewell,et al. Pulmonary veno-occlusive disease after chemotherapy. , 1986, Thorax.
[63] T. Takahashi,et al. Pulmonary vascular disease in secundum atrial septal defect with pulmonary hypertension. , 1986, Chest.
[64] C. Oakley,et al. Factors that influence the outcome of primary pulmonary hypertension. , 1986, British heart journal.
[65] F. Nistal,et al. Comparison of Doppler-determined elevated pulmonary arterial pressure with pressure measured at cardiac catheterization. , 1986, The American journal of cardiology.
[66] R. Barst. Pharmacologically induced pulmonary vasodilatation in children and young adults with primary pulmonary hypertension. , 1986, Chest.
[67] H. Tazelaar,et al. TWENTY-EIGHT CASES OF HUMAN HEART-LUNG TRANSPLANTATION , 1986, The Lancet.
[68] S. Jamieson,et al. Primary pulmonary hypertension and pregnancy. , 1986, Chest.
[69] R. Us. The endothelial surface and responses to injury. , 1986 .
[70] L. Rubin,et al. Primary Pulmonary Hypertension: AN ANALYSIS OF 28 CASES AND A REVIEW OF THE LITERATURE , 1986 .
[71] J. Theodore,et al. Long-term clinical trials in pulmonary hypertension. Long overdue. , 1986, Chest.
[72] B. Groves,et al. A comparison of the acute hemodynamic effects of prostacyclin and hydralazine in primary pulmonary hypertension. , 1985, American heart journal.
[73] D. Langleben,et al. Decreased half-life of fibrinogen in primary pulmonary hypertension. , 1985, Thrombosis research.
[74] M. Packer. Does pulmonary vasoconstriction play an important role in patients with primary pulmonary hypertension? A skeptic's view of vasodilator therapy. , 1985, Chest.
[75] C. Wagenvoort,et al. Comparison of primary plexogenic arteriopathy in adults and children. A morphometric study in 40 patients. , 1985, British heart journal.
[76] A. Van Tosh,et al. Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound. , 1985, Journal of the American College of Cardiology.
[77] B. Brundage,et al. The effect of vasodilator therapy on the clinical outcome of patients with primary pulmonary hypertension. , 1985, Circulation.
[78] W. Edwards,et al. Primary pulmonary hypertension: a histopathologic study of 80 cases. , 1985, Mayo Clinic proceedings.
[79] M. Packer,et al. Adverse hemodynamic and clinical effects of calcium channel blockade in pulmonary hypertension secondary to obliterative pulmonary vascular disease. , 1984, Journal of the American College of Cardiology.
[80] V. Fuster,et al. Primary pulmonary hypertension: natural history and the importance of thrombosis. , 1984, Circulation.
[81] B. Brundage,et al. Primary pulmonary hypertension. Current update. , 1984, JAMA.
[82] A. Takeshita,et al. Noninvasive assessment of right ventricular systolic pressure in atrial septal defect: analysis of the end-systolic configuration of the ventricular septum by two-dimensional echocardiography. , 1984, The American journal of cardiology.
[83] S. Rich,et al. Characteristics of surviving and nonsurviving patients with primary pulmonary hypertension. , 1984, The American journal of medicine.
[84] J. S. Bower,et al. Differentiation of patients with primary and thromboembolic pulmonary hypertension. , 1984, Chest.
[85] N. Hill,et al. Pulmonary hypertensive diseases. , 1984, Chest.
[86] G. Hutchins,et al. Primary pulmonary hypertension and cirrhosis: are they related? , 2015, The American review of respiratory disease.
[87] C. Mélot,et al. Effects of nifedipine on ventilation/perfusion matching in primary pulmonary hypertension. , 1983, Chest.
[88] R. Magorien,et al. Captopril in Primary Pulmonary Hypertension , 1983, Circulation.
[89] L. Blaser. New primary pulmonary hypertension registry , 1982 .
[90] L. Reid,et al. Pulmonary veno-occlusive disease in siblings: case reports and morphometric study. , 1982, Human Pathology.
[91] B. Groves,et al. Prostacyclin‐induced Acute Pulmonary Vasodilation in Primary Pulmonary Hypertension , 1982, Circulation.
[92] J. Douglas,et al. Pulmonary hypertension and fenfluramine , 1981 .
[93] S. Pugsley,et al. Effect of digoxin on right ventricular function in severe chronic airflow obstruction. A controlled clinical trial. , 1981, Annals of internal medicine.
[94] V. Fuster,et al. The natural history of idiopathic pulmonary hypertension , 1981 .
[95] N. Kanemoto. Electrocardiogram in primary pulmonary hypertension. , 1978, European journal of cardiology.
[96] G. Cherian,et al. Primary pulmonary hypertension. , 1997 .
[97] G. Cherian,et al. Primary pulmonary hypertension in India. , 1981, Indian heart journal.
[98] H. Sasamoto,et al. Pulmonary hemodynamics in primary pulmonary hypertension. , 1979, Japanese heart journal.
[99] J. Spijker,et al. Capillary haemangiomatosis of the lungs , 1978, Histopathology.
[100] J. R. Kuipers,et al. Familial pulmonary veno-occlusive disease: a case report. , 1977, Thorax.
[101] W. Edwards,et al. Clinical primary pulmonary hypertension: three pathologic types. , 1977, Circulation.
[102] S. Watanabe,et al. Clinical and experimental study upon primary pulmonary hypertension. , 1976, Japanese circulation journal.
[103] C. Oakley,et al. Regression of primary pulmonary hypertension. , 1976, British heart journal.
[104] R. Mccabe,et al. FAILURE OF CANINE KIDNEY PRESERVATION USING SACKS II SOLUTION , 1975, The Lancet.
[105] D. Harrison,et al. Echocardiographic features of primary pulmonary hypertension. , 1974, The American journal of cardiology.
[106] E. Trell. Benign, idiopathic pulmonary hypertension? Two further cases of unusually long duration. , 2009, Acta medica Scandinavica.
[107] J. LeónCastro,et al. [Primary pulmonary hypertension]. , 1971, Revista clinica espanola.
[108] C. Wagenvoort,et al. Primary Pulmonary Hypertension: A Pathologic Study of the Lung Vessels in 156 Clinically Diagnosed Cases , 1970 .
[109] A. L. Brown,et al. Primary pulmonary hypertension. , 1970, The American journal of medicine.
[110] A. Charters,et al. Primary pulmonary hypertension of unusually long duration. , 1970, British heart journal.
[111] C. Wooley. COOPERATIVE STUDY ON CARDIAC CATHETERIZATION , 1969 .
[112] J. Somerville,et al. Oral contraceptives and progressive pulmonary vascular disease. , 1968, Lancet.
[113] B. M. Baker,et al. Ballistocardiography: Predictor of Coronary Heart Disease , 1968, Circulation.
[114] N. Fowler,et al. Idiopathic and thromboembolic pulmonary hypertension , 1966 .
[115] H. Mcintosh,et al. Primary Pulmonary Hypertension: Review of Clinical Features and Pathologic Physiology with a Report of Pulmonary Hemodynamics Derived from Repeated Catheterization , 1962, Circulation.
[116] C. Wagenvoort. Vasoconstriction and Medial Hypertrophy in Pulmonary Hypertension , 1960, Circulation.
[117] P. Wood. PULMONARY HYPERTENSION WITH SPECIAL REFERENCE TO THE VASOCONSTRICTIVE FACTOR* , 1958, British heart journal.
[118] J. Edwards,et al. The Pathology of Hypertensive Pulmonary Vascular Disease: A Description of Six Grades of Structural Changes in the Pulmonary Arteries with Special Reference to Congenital Cardiac Septal Defects , 1958, Circulation.
[119] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[120] D. Heath,et al. Hypertensive Pulmonary Vascular Disease , 1956, Circulation.
[121] D. Dresdale,et al. Primary pulmonary hypertension. I. Clinical and hemodynamic study. , 1951, The American journal of medicine.